Shahzaade Robinson, APRN

Shahzaade Robinson practices at Palm Beach Gardens Medical Center in Palm Beach Gardens, Florida, part of Tenet Healthcare.

Shahzaade Robinson's NPI, 1659098994, was assigned on October 26, 2022. Shahzaade Robinson holds Florida license 11022739.

Shahzaade Robinson's primary practice is Palm Beach Gardens Medical Center, at 3360 Burns Rd, Palm Beach Gardens, FL 33410 in Palm Beach County. The practice phone is (561) 622-1411.

Shahzaade Robinson's primary practice is Palm Beach Gardens Medical Center in Palm Beach Gardens, Florida, part of Tenet Healthcare. Shahzaade Robinson is also affiliated with Jupiter Medical Center. The medical group on file is Tampa General Hospital Cancer Center of South Florida.

Dmand AI tracks the electronic health record (EHR) system at each site where Shahzaade Robinson practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Shahzaade Robinson's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Shahzaade Robinson is licensed in Florida.

CMS data shows 22 Medicare services from Shahzaade Robinson across 1 procedure code in 2024, for 24 Medicare patients. Medicare paid $1,732 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 24 Medicare patients who saw Shahzaade Robinson in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shahzaade Robinson's median patient age at 72, with 51% women.

In 2024, Shahzaade Robinson wrote 247 Medicare Part D claims for 83 patients. 60% of them were for generic drugs. CMS names the drug for 151 of them, across 6 drugs with 11 or more claims each, at $49,771 in total drug cost.

Shahzaade Robinson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Shahzaade Robinson from 2 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $152.